The US regulator approved the purchase of Irish Shire by the Japanese company Takeda Pharmaceutical for 61 million dollars

The US Federal Trade Commission approved the purchase of the Irish pharmaceutical company Shire by Japanese Takeda Pharmaceutical, the largest pharmaceutical company in Asia, for 46 billion pounds sterling. The message of Takeda said that the deal would lead the Japanese company into the top 10 pharmaceutical companies in the world in terms of revenue. Takeda expects that the deal, which is the largest in the history of deals of the Japanese companies with the purchase of foreign assets, will be closed in the first half of 2019. The deal has yet to be agreed in a number of other countries, including the EU, Japan and China.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong